MyStart

Frankfurt, Germany Founded: 2011 • Age: 15 yrs
Researches biopharmaceuticals for diseases like diabetes and respiratory conditions.

About MyStart

MyStart is a Healthcare company based in Frankfurt (Germany) founded in 2011. Researches biopharmaceuticals for diseases like diabetes and respiratory conditions. It operates on a B2B and D2C model. MyStart offers products and services including Vaccines, Diabetes Treatments, and Respiratory Therapies. Its focus areas include Biopharmaceuticals, Therapeutics, Diabetes Treatments and Respiratory Diseases. Its legal entity is Sanofi.

Company details

Sanofi operates as a global biopharmaceutical company with its headquarters in Paris and a major site in Frankfurt, Germany. It focuses on innovating therapies for various health challenges, including respiratory diseases, diabetes, and cancer, through research, development, and partnerships. The company applies AI to enhance drug discovery and emphasizes sustainability, serving healthcare providers and patients worldwide with a commitment to improving global health outcomes.

Operational Areas

Products & Services of MyStart

MyStart offers a comprehensive portfolio of products and services, including Vaccines, Diabetes Treatments, and Respiratory Therapies.

Vaccines
Immunology

Products for preventing infectious diseases and boosting immunity.

Diabetes Treatments
Endocrinology

Medications for managing blood sugar in diabetic patients.

Respiratory Therapies
Pulmonary Care

Solutions for treating asthma and other lung conditions.

Apps and channels of MyStart

its YouTube channel Sanofi Mediathek has 8.13K subscribers and 30 videos.

Sanofi Mediathek
YouTube 8.13K subscribers 30 videos Science & Technology
Open channel

Videos from MyStart

The most watched videos on MyStart's YouTube channel, Sanofi Mediathek (8.13K subscribers). Click a video to play it here.

Influenza: die echte Grippe
2.2K views
Grippeimpfung? Nein? Warum nicht?
1.9K views
Hightech trifft Innovation: Ein exklusiver Blick hinter die Kulissen unseres Sanofi BioCampus
1.8K views
Lunge: Was ist, wenn das Atmen nicht mehr normal möglich ist?
1.1K views

More on Sanofi Mediathek.

Web traffic of MyStart

Websites that share an audience with MyStart (sanofi.de).

Similar websites

Websites whose visitors overlap most with MyStart. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
merck.de
76%
12.3K#973,850View details
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about MyStart

MyStart was founded in 2011.

MyStart is headquartered in Frankfurt, Germany. It is registered at Frankfurt, Hesse, Germany.

Sanofi operates as a global biopharmaceutical company with its headquarters in Paris and a major site in Frankfurt, Germany. It focuses on innovating therapies for various health challenges, including respiratory diseases, diabetes, and cancer, through research, development, and partnerships. The company applies AI to enhance drug discovery and emphasizes sustainability, serving healthcare providers and patients worldwide with a commitment to improving global health outcomes.

MyStart offers Vaccines, Diabetes Treatments, and Respiratory Therapies.

MyStart operates through Sanofi.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available